Neel R. Nabar, MD, PhD

Heme/Onc Fellow @PennMedicine | Physician-Scientist | Alum @NIH, @KarolinskaInst, @JeffersonUniv

[E. John Wherry @EJohnWherry]

Trump terminated $1.8B in science funding in 40 days. A loss of ~$4.6B in future economic activity. Means a higher fraction of new discoveries will be overseas. We'll be buying our future drugs from other countries...and, oh - they'll have tariffs on them.
https://t.co/dICsYOyBIv

[Neel R. Nabar, MD, PhD @NeelNabar]

@MatthewHoMD @ZhuoerXie @n_gangat @Dr_AmerZeidan Fantastic @MatthewHoMD. I like the MDS/AML overlap definition by ICC (10-19% blasts in certain subgroups) - useful in terms of clinical trajectory/management.

Food for thought - if including disorders of myeloid clonal hematopoeisis without neoplasia, should VEXAS be here?!

[Nico Gagelmann @NicoGagelmann]

Brilliant algorithm on how to approach thrombocytosis

Source: @MatthewHoMD

[Saarang Deshpande, MD @SR_DeshpandeMD]

Introducing my classical hematology reading list!
https://t.co/KWlnaRkDs0

Over the past few years, I’ve noticed that the best physicians I’ve worked with have a keen understanding of how key papers from this era of proliferating research apply to complex clinical cases.

[Neel R. Nabar, MD, PhD @NeelNabar]

@Mark_Heslin @febrilepodcast Antibiotics for sure - but to anticoagulate or not to anticoagulate?

[Marco Ruella @MarcoRuella]

Next step is to identify the specific barriers and develop strategies to overcome them. @NEJMEvidence

[Ben Rosenthal, MD @RosenthalBenjam]

👏 way to go @marlask! What an insightful and important talk on albumin use disparities in SBP in the VOCAL cohort

🚨 race/ethnicity and regional disparities exist
🚨 hepatology and nephrology consultants increase albumin use

@PennIMResidents @penngihep @serperm @nadimmahmud

[Ben Rosenthal, MD @RosenthalBenjam]

The end of an era. Thank you for everything @therealpenntb 👑.

You’ve made so many people feel at home in this program. Enjoy your last day tomorrow.

@PennIMResidents @PennMedicine

[Gabriele Casirati @CasiratiG]

I'm thrilled to announce that our work, 'Epitope Editing Enables Targeted Immunotherapy of Acute Myeloid Leukemia,' is out today in Nature journal!

Link: https://t.co/nC05EjWMPw
doi: https://t.co/t8CWop6Z4k

[Miheer Pujara @mihematology]

I put together a talk on bispecific T cell engagers in lymphoma and myeloma for @UMNHOT grand rounds last week

Here’s a quick overview of the four phase 2 BiTE trials published in 2022 including:

• Glofitamab
• Epcoritamab
• Mosunetuzumab
• Teclistamab

🧵(1/7)

[Ryan O'Keefe @ROKeefeMD]

During my first PGY-2 night float block, I admitted over 70 patients in 2 weeks.

Many of these patients presented with syncope.

I decided to create a framework for approaching syncope, including a checklist and a templated HPI intake.

- Thread -

#MedTwitter #MedEd #Syncope

[Neel R. Nabar, MD, PhD @NeelNabar]

If we want precision oncology to take hold, we need subspecialty specific minimal data elements incorporated into the EHR to enable data sharing and improve outcomes data.

[Richard Schilsky @rschilsky]

Genomic testing a key part of cancer care. https://t.co/B8EEsf1Ub2

[Neel R. Nabar, MD, PhD @NeelNabar]

INCREDIBLY EXCITED to join the @PennMedicine Hematology/Oncology fellowship. So thankful for my mentors, those on twitter @MarcoRuella, @MMarmarelis, @JuddPHL, and those not (John Kehrl, Peter Klein). See you soon @erin_aakhus, @AMarshallMD

[Sayed Tabatabai, M.D. @TheRealDoctorT]

Someone who’s always immaculately dressed at work sent me this little explanation as to why.

I wasn’t expecting reason #3, and it hit me hard. It’ll stay with me.

[Melina Marmarelis @MMarmarelis]

Loving our rounding view in the new @PennMedicine building. Solid Oncology team here! @NeelNabar @PennCancer

[Immune Regulation News @Immune_News]

LRRK2 is required for CD38-mediated NAADP-Ca2+ signaling and the downstream activation of transcription factor EB in immune cells, reports a team led by @NIH Drs. Neel Nabar and John Kehrl.
https://t.co/HCxLiZLukm

[Neel R. Nabar, MD, PhD @NeelNabar]

@JeffersonUniv Thanks @JeffersonUniv proud to be an Alum!

[Paul Bieniasz @PaulBieniasz]

Nature conducts more coronavirus 'gain of function' experiments every minute, than humans have ever conceived.

[Rep. Megan L. Srinivas, MD MPH @YourlocalIDdoc]

Can we relax precautions like #masking now that we have #vaccines?

No. Vaccines help prevent severe infection/symptoms, but vaccinated people may still be able to be carriers. Additionally, new variants can change the efficacy. We need to...
(1/4)